Belimumab: In Systemic Lupus Erythematosus

Author： Burness Celeste B.   McCormack Paul L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.18, 2011-12, pp. : 2435-2444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 2143-2153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa   Perl Andras  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite

Neuropsychiatric Systemic Lupus Erythematosus

By  

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 449-457

Bentham Science Publishers

Access to resources Recommend Favorite

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus

By van Vollenhoven Ronald F  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy in Systemic Lupus Erythematosus

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 677-684

Bentham Science Publishers

Access to resources Recommend Favorite